Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.42B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.74B |
| 5 |
Amazon
AMZN
|
+$1.27B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.54B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$549M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$452M |
| 4 |
Stellantis
STLA
|
+$326M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$239M |
Sector Composition
| 1 | Technology | 29.05% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 10.8% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Design Therapeutics
DSGN
$347M
| $99K | ﹤0.01% |
15,820
-1,397
| -8% | -$8.74K |
|
3252
iShares MSCI KLD 400 Social ETF
DSI
$4.9B
| $99K | ﹤0.01% |
+1,179
| New | +$99K |
|
3253
eHealth
EHTH
$124M
| $99K | ﹤0.01% |
12,235
-8,672
| -41% | -$70.2K |
|
3254
Five Star Bancorp
FSBC
$701M
| $99K | ﹤0.01% |
4,405
-1,983
| -31% | -$44.6K |
|
3255
KB Financial Group
KB
$30.7B
| $99K | ﹤0.01% |
2,722
| – | – |
|
3256
Cellebrite
CLBT
$4.29B
| $98K | ﹤0.01% |
+13,626
| New | +$98K |
|
|
ABST
3257
DELISTED
Absolute Software Corporation Common Stock
ABST
| $98K | ﹤0.01% |
8,594
+7,972
| +1,282% | +$90.9K |
|
3258
Clarus
CLAR
$151M
| $97K | ﹤0.01% |
10,515
-4,046
| -28% | -$37.3K |
|
3259
Richardson Electronics
RELL
$143M
| $97K | ﹤0.01% |
5,817
-14,544
| -71% | -$243K |
|
3260
Entrada Therapeutics
TRDA
$200M
| $97K | ﹤0.01% |
6,440
-3,788
| -37% | -$57.1K |
|
|
DSKE
3261
DELISTED
Daseke, Inc. Common Stock
DSKE
| $96K | ﹤0.01% |
13,527
-6,825
| -34% | -$48.4K |
|
3262
Assertio
ASRT
$78.5M
| $95K | ﹤0.01% |
17,402
-108,855
| -86% | -$594K |
|
3263
Generation Bio
GBIO
$40.1M
| $95K | ﹤0.01% |
1,740
-1,279
| -42% | -$69.8K |
|
3264
Hovnanian Enterprises
HOV
$907M
| $95K | ﹤0.01% |
957
-1,491
| -61% | -$148K |
|
3265
Oportun Financial
OPRT
$280M
| $95K | ﹤0.01% |
15,881
-20,155
| -56% | -$121K |
|
3266
SES AI
SES
$428M
| $95K | ﹤0.01% |
+38,615
| New | +$95K |
|
3267
Toyota
TM
$258B
| $95K | ﹤0.01% |
592
| – | – |
|
3268
Monte Rosa Therapeutics
GLUE
$302M
| $94K | ﹤0.01% |
13,635
-1,534
| -10% | -$10.6K |
|
|
NOA
3269
North American Construction
NOA
$396M
| $94K | ﹤0.01% |
4,907
+4,526
| +1,188% | +$86.7K |
|
3270
SPDR S&P Aerospace & Defense ETF
XAR
$4.07B
| $94K | ﹤0.01% |
770
+100
| +15% | +$12.2K |
|
|
ENFN
3271
DELISTED
Enfusion, Inc.
ENFN
| $94K | ﹤0.01% |
8,379
-5,243
| -38% | -$58.8K |
|
3272
Costamare
CMRE
$1.46B
| $93K | ﹤0.01% |
9,629
-17,208
| -64% | -$166K |
|
3273
Rimini Street
RMNI
$436M
| $93K | ﹤0.01% |
19,312
-5,770
| -23% | -$27.8K |
|
3274
Vivid Seats
SEAT
$108M
| $93K | ﹤0.01% |
589
-59
| -9% | -$9.32K |
|
3275
C4 Therapeutics
CCCC
$189M
| $92K | ﹤0.01% |
33,368
-13,995
| -30% | -$38.6K |
|